Toward the nanoengineering of mature, well-patterned and vascularized organoids.

Nanomedicine (Lond)

Center of Excellence for Stem Cells & Regenerative Medicine (CESC), Zewail City of Science & Technology, 6th October city, Giza, 12578, Egypt.

Published: June 2021

Download full-text PDF

Source
http://dx.doi.org/10.2217/nnm-2021-0074DOI Listing

Publication Analysis

Top Keywords

nanoengineering mature
4
mature well-patterned
4
well-patterned vascularized
4
vascularized organoids
4
nanoengineering
1
well-patterned
1
vascularized
1
organoids
1

Similar Publications

Influenza epidemics remain a global public health challenge. Vaccination with nucleic acid-based vaccines, which trigger strong cellular and humoral immune responses, represents a promising approach for preventing virus infection. However, its effectiveness relies on efficient delivery and an immunoadjuvant.

View Article and Find Full Text PDF

Engineering biointerfaces with nanoscale clustering of integrin-binding cell adhesive peptides is critical for promoting receptor redistribution into signaling complexes. Skeletal muscle cells are exquisitely sensitive to integrin-mediated signaling, yet biomaterials supporting myogenesis through control of the density and nanodistribution of ligands have not been developed. Here, materials are developed with tailorable cell adhesive ligands distribution at the interface by independently controlling their global and local density to enhance myogenesis, by promoting myoblast growth and myotube formation.

View Article and Find Full Text PDF

Organoids are transformative in vitro model systems that mimic features of the corresponding tissue in vivo. However, across tissue types and species, organoids still often fail to reach full maturity and function because biochemical cues cannot be provided from within the organoid to guide their development. Here we introduce nanoengineered DNA microbeads with tissue mimetic tunable stiffness for implementing spatio-temporally controlled morphogen gradients inside of organoids at any point in their development.

View Article and Find Full Text PDF

Turning foes to friends: Advanced " nanovaccine" with dual immunoregulation for enhanced immunotherapy of metastatic triple-negative breast cancer.

Bioact Mater

September 2024

State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, PR China.

As a "cold tumor", triple-negative breast cancer (TNBC) exhibits limited responsiveness to current immunotherapy. How to enhance the immunogenicity and reverse the immunosuppressive microenvironment of TNBC remain a formidable challenge. Herein, an " nanovaccine" Au/CuNDs-R848 was designed for imaging-guided photothermal therapy (PTT)/chemodynamic therapy (CDT) synergistic therapy to trigger dual immunoregulatory effects on TNBC.

View Article and Find Full Text PDF

The topology of the transcription factor network (TFN) of is far from uniform, with 22 global regulator (GR) proteins controlling one-third of all genes. So far, their production rates cannot be tracked by comparable fluorescent proteins. We developed a library of fluorescent reporters for 16 GRs for this purpose.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!